Predictors of response to pharmacotherapy in children and adolescents with psychiatric disorders: A combined post hoc analysis of four clinical trial data
Authors:
Open Access
- 2 November 2022
- journal article
- research article
- Published by Wiley in Neuropsychopharmacology Reports
- Vol. 42 (4) , 516-520
Abstract
Objective The prediction of response to pharmacotherapy has not been sufficiently explored in children and adolescents with psychiatric disorders, which was addressed in this study. Methods Data from four double-blind, placebo-controlled studies (sertraline and fluvoxamine for anxiety disorders, risperidone for autistic disorder, and fluoxetine for major depressive disorder) in children and adolescents funded by the National Institute of Mental Health were used. The response was defined as a score of 1 or 2 on the Clinical Global Impression-Global Improvement (CGI-I) at the endpoint. Logistic regression analysis was performed to evaluate associations between response status and the following variables: sex, diagnosis, treatment allocation, and CGI-Severity of Illness (CGI-S) score at baseline. Moreover, the presence of early improvement (a score of <= 3 in the CGI-I) at Week 1 was added to the independent variables in an additional binary logistic regression analysis, using the data from two studies. Results A total of 599 patients were included in the analysis. In the binary logistic regression analysis, active drug use (odds ratio [OR] = 8.64, P < 0.001) and female sex (OR = 1.89, P = 0.002) were significantly associated with treatment response. In the second binary logistic regression, the presence of early improvement in the CGI-I (OR = 3.47, P = 0.009), as well as active drug use (OR = 15.05, P < 0.001) and female sex (OR = 2.87, P = 0.016), were associated with subsequent responses. Conclusion Allocation to active drugs, female sex, and early improvement may predict treatment response to pharmacotherapy among children and adolescents with psychiatric disorders.Keywords
Funding Information
- National Institutes of Health
This publication has 21 references indexed in Scilit:
- Are child and adolescent mental health problems increasing in the 21st century? A systematic reviewAustralian & New Zealand Journal of Psychiatry, 2014
- Trajectories of individual symptoms in remitters versus non-remitters with depressionJournal of Affective Disorders, 2013
- Lifetime Prevalence of Mental Disorders in U.S. Adolescents: Results from the National Comorbidity Survey Replication–Adolescent Supplement (NCS-A)Journal of the American Academy of Child & Adolescent Psychiatry, 2010
- Child and adolescent psychiatry: past scientific achievements and challenges for the futureEuropean Child & Adolescent Psychiatry, 2010
- Aripiprazole in the Treatment of Irritability in Children and Adolescents With Autistic DisorderPediatrics, 2009
- Early Prediction of Acute Antidepressant Treatment Response and Remission in Pediatric Major Depressive DisorderJournal of the American Academy of Child & Adolescent Psychiatry, 2009
- Cognitive Behavioral Therapy, Sertraline, or a Combination in Childhood AnxietyNew England Journal of Medicine, 2008
- Fluoxetine, Cognitive-Behavioral Therapy, and Their Combination for Adolescents With DepressionJAMA, 2004
- Evidence-Based Treatments in Child and Adolescent Psychiatry: An InventoryJournal of the American Academy of Child & Adolescent Psychiatry, 2003
- Risperidone in Children with Autism and Serious Behavioral ProblemsNew England Journal of Medicine, 2002